Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

New blood clotting analysis system could help determine effects antithrombotic (anti-clotting) drugs

A new blood clotting analysis system designed in Japan makes it easier to determine the effects of taking one or more antithrombotic (anti-clotting) drugs.

29 Jan 2016

Study shows regular caffeine consumption does not lead to extra heartbeats

Contrary to current clinical belief, regular caffeine consumption does not lead to extra heartbeats, which, while common, can lead in rare cases to heart- or stroke-related morbidity and mortality, according to UC San Francisco researchers.

27 Jan 2016

Patients who receive information about coronary artery disease risk make improvements to health behaviors

A new study led by researchers at Brigham and Women's Hospital has found that providing unanticipated information about risk of coronary artery disease during a genetic risk assessment for Alzheimer's disease helped some participants cope with their results, and also motivated participants to make changes to their health behaviors.

27 Jan 2016

New classification of coronary congenital diseases helps surgeons identify secondary defects

A new classification of coronary congenital diseases is set to help surgeons identify secondary defects in the operating theatre. The scheme is outlined in a novel European Society of Cardiology position paper published today in Cardiovascular Research.1 Clinical cardiologists will also know what to look for on cardiovascular images.

11 Jan 2016

FDA-approved, once-daily 24-hour aspirin now available for prevention of stroke and acute cardiac events

New Haven Pharmaceuticals, Inc. today announced the availability by prescription of DURLAZA, the first and only 24-hour, extended-release aspirin capsules (162.5mg) approved by the U.S. Food and Drug Administration (FDA) for the secondary prevention of stroke and acute cardiac events, including myocardial infarction (heart attack) in high-risk cardiovascular patients.

7 Jan 2016

QT Vascular reports initial results from first-in-human study of Chocolate Heart drug-coated balloon

QT Vascular Ltd., together with its subsidiaries (the "Company" or "QT Vascular", and together with its subsidiaries, the "Group"), a global company engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of vascular disease, announce today the release of the initial results from the first-in-human study of its unique drug-coated balloon, Chocolate Heart.

7 Jan 2016

Email communications between patients, physicians improve overall health

A third of patients with chronic conditions who exchanged secure emails with their doctors said that these communications improved their overall health, according to a Kaiser Permanente study published today in the American Journal of Managed Care.

22 Dec 2015

New mobile app empowers individuals to assess, enhance daily overall heart health

Leading cardiologist Valentin Fuster, MD, PhD, has developed a free mobile application called "Circle of Health" to empower individuals around the globe to take action to comprehensively assess and enhance their daily overall heart health. Cardiovascular diseases are the number one cause of mortality in the world.

17 Dec 2015

Sedentary behaviour worsens health of heart disease patients

Patients with heart disease who sit a lot have worse health even if they exercise, reveals research from the University of Ottawa Heart Institute, and published today in the European Journal of Cardiovascular Prevention.

26 Nov 2015

Angina in women linked with abnormal heart blood flow

Chest pain in female-pattern heart disease is linked with abnormal heart blood flow, demonstrated with a drug commonly used to alleviate chest pain patients with coronary artery disease, which was found to be ineffective in patients with moderate female-pattern heart disease, but may offer some relief for sicker patients, a new Cedars-Sinai Heart Institute study shows.

12 Nov 2015

Vitamin D deficiency puts people at risk of developing heart problems

A lack of vitamin D can result in weak bones. Recent studies also show that vitamin D deficiency is linked to more serious health risks such as coronary artery disease, heart attacks, and strokes.

10 Nov 2015

New Haven Pharmaceuticals' DURLAZA drug delivers sustained antiplatelet control for full 24 hours

New Haven Pharmaceuticals, Inc. today announced new study data that shows the company's FDA-approved drug DURLAZA delivers sustained antiplatelet control for a full 24-hour period in high-risk patients.

10 Nov 2015

Study explores prevalence of myocardial scars in middle-aged and older population

In a multiethnic, middle-aged and older study population, the prevalence of myocardial scars (evidence of a heart attack) was nearly 8 percent, of which nearly 80 percent were unrecognized by electrocardiography or clinical evaluation, according to a study in the November 10 issue of JAMA.

9 Nov 2015

ReDy receives CE clearance for third-generation Renal Denervation System

Renal Dynamics' third-generation Renal Denervation System received CE clearance and is now commercially available in Europe for treatment of Resistant Hypertension. The ReDy Renal Denervation System is based on a novel multi-electrode ablation technology that delivers a pre-determined RF ablation set with a single positioning.

4 Nov 2015

CVIA journal launched at the opening ceremony of 26th GW-ICC meeting

Cardiovascular Innovations and Applications (CVIA), a new journal affiliated with the Great Wall-International Congress of Cardiology, was introduced today at the opening ceremony of GWICC by Congress Chairman Prof. Changsheng Ma.

3 Nov 2015

Noninvasive CT scans far better than stress tests at spotting clogged arteries

Results of a head-to-head comparison study led by Johns Hopkins researchers show that noninvasive CT scans of the heart's vessels are far better at spotting clogged arteries that can trigger a heart attack than the commonly prescribed exercise stress that most patients with chest pain undergo.

27 Oct 2015

IPF-PRO Registry data sheds light on characteristics of people with idiopathic pulmonary fibrosis

Boehringer Ingelheim Pharmaceutical, Inc. today announced initial results of the first 49 people enrolled in the IPF-PRO Registry, which shed light on characteristics of people with IPF at the time of diagnosis.

23 Oct 2015

Stanford scientists identify a progenitor cell type that could repair damaged arteries

By tracking a single cell in a growing heart, scientists from Stanford University have discovered a cell type that could repair damaged arteries.

20 Oct 2015

Team-based delivery models can improve quality of care in patients with cardiovascular disease

Patients with coronary artery disease, heart failure, and atrial fibrillation receive comparable outpatient care from physicians and advanced practice providers-- physician assistants and nurse practitioners - although all clinicians fell short in meeting performance measures, according to a study published today in the Journal of the American College of Cardiology.

13 Oct 2015

CardioDx announces national agreement with Quest Diagnostics to expand access to Corus CAD blood test

CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced a national specimen-draw agreement with Quest Diagnostics DGX, +1.23% the world's leading provider of diagnostic information services, that will expand patient and clinician access to the Corus CAD lab-developed blood test for aiding the assessment of obstructive coronary artery disease (CAD).

From Quest Diagnostics 18 Sep 2015

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

New blood clotting analysis system could help determine effects antithrombotic (anti-clotting) drugs

Study shows regular caffeine consumption does not lead to extra heartbeats

Patients who receive information about coronary artery disease risk make improvements to health behaviors

New classification of coronary congenital diseases helps surgeons identify secondary defects

FDA-approved, once-daily 24-hour aspirin now available for prevention of stroke and acute cardiac events

QT Vascular reports initial results from first-in-human study of Chocolate Heart drug-coated balloon

Email communications between patients, physicians improve overall health

New mobile app empowers individuals to assess, enhance daily overall heart health

Sedentary behaviour worsens health of heart disease patients

Angina in women linked with abnormal heart blood flow

Vitamin D deficiency puts people at risk of developing heart problems

New Haven Pharmaceuticals' DURLAZA drug delivers sustained antiplatelet control for full 24 hours

Study explores prevalence of myocardial scars in middle-aged and older population

ReDy receives CE clearance for third-generation Renal Denervation System

CVIA journal launched at the opening ceremony of 26th GW-ICC meeting

Noninvasive CT scans far better than stress tests at spotting clogged arteries

IPF-PRO Registry data sheds light on characteristics of people with idiopathic pulmonary fibrosis

Stanford scientists identify a progenitor cell type that could repair damaged arteries

Team-based delivery models can improve quality of care in patients with cardiovascular disease

CardioDx announces national agreement with Quest Diagnostics to expand access to Corus CAD blood test

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in